News & Updates

Smith Drug Company supports end to pharmacy fees that drive up drug costs

Mar 30, 2017 Tags: Capitol Hill, Medicare, NCPA, Pharmaceuticals, Smith Drug Company

Smith Drug Company and Burlington Drug Company recently joined with more than 115 other health care groups to endorse bipartisan legislation that would prohibit pharmacy benefit managers from adding retroactive charges on Medicare Part D prescription drugs.

The effect of those fees is to raise costs for seniors, taxpayers and pharmacies.

Read more

South Carolina’s Third-Largest Privately Held Company Announces New CEO

Mar 1, 2017 Tags: Business, J M Smith Corporation, Smith Drug Company

Alan Turfe to Lead J M Smith Corporation

SPARTANBURG, S.C. – The Board of Directors of J M Smith Corporation has named A. Alan Turfe as the new CEO and Chairman of the Board, effective March 1, 2017, following the retirement of long-time Chairman and CEO William R. Cobb. Turfe was selected by the board following a nationwide search, and brings a wealth of experience in the life sciences, medical device, e-commerce and automotive industries.

“In a pool of incredibly qualified candidates, Alan demonstrated the leadership skills, business acumen and background best suited to lead J M Smith Corporation into the future,” said board member Terry Cash, who chaired the search committee. “Alan is growth-minded and believes, as we do, that the future is bright for J M Smith Corporation. We believe he will both honor the proud history of this organization while leading it through the dynamic times ahead.”

Read more

Flu Update

Feb 3, 2017 Tags: CDC, Influenza

ATLANTA — The flu is continuing to impact the United States, especially across the Southeast U.S. for the week ended Jan. 21 the Centers for Disease Control and Prevention reported Friday.

The proportion of outpatient visits for influenza-like illness was 3.4%, well above the national baseline of 2.2% and an increase from the week prior ILI report of 3.2%.

Read more

Burlington Drug Company Joins J M Smith Corporation

Jan 2, 2017 Tags: Business, J M Smith Corporation, Smith Drug Company

Burlington Drug Company has become a subsidiary of J M Smith Corporation as of January 1, 2017. Burlington Drug Company will continue to manage all operations, customer service and sales functions out of the current facility in Milton, Vermont. This business combination will enable J M Smith Corporation to expand market offerings to the important Northeast market of the United States, while giving Burlington Drug Company customers access to a variety of new tools, services and products that will create additional growth opportunities for their businesses.

Read more